ER+/HER2+ Metastatic Breast Cancer
2 विचारों
• 07/03/23
0
0
एम्बेड
administrator
ग्राहकों
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां